Adenosine physiology and pharmacology: How about A2 receptors?

Pharmacology and Therapeutics

Volumn 71, Issue 3, 1996, Pages 325-335

  Daval, Jean Luc ^a   Nicolas, Frédéric ^a   Doriat, Jean François ^a  

^a INSERM   (France)

Author keywords

A2 receptors; adenosine; biochemical properties; central and peripheral physiology; maturation; therapeutic potential

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR; ADENYLATE CYCLASE;

APOPTOSIS; BEHAVIOR; CARDIOVASCULAR SYSTEM; ENERGY METABOLISM; GENE EXPRESSION; HUMAN; HYPOXIA; INFLAMMATION; ISCHEMIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR AFFINITY; RESPIRATORY SYSTEM; REVIEW;

ADENOSINE; ANIMALS; HUMANS; RECEPTORS, PURINERGIC P1;

EID: 0029921939     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(96)00094-0     Document Type: Review

References (114)

1. Adén, U., Lindström, K., Bona, E., Hagberg, H. and Fredholm, B. B. (1994) Changes in adenosine receptors in the neonatal rat brain following hypoxic ischemia. Mol. Brain Res. 23: 354-368.
2. Aranda, J. V., Beharry, K., Laudignon, N. and Sasyniuk, B. I. (1989) Ontogeny of adenosine production and degradation and its implications in neonatal cerebral blood flow regulation. Dev. Pharmacol. Ther. 13: 96-103.
3. Bakris, G. L., Saucer, E. R., Hussey, J. L., Fisher, J. W., Gaber, A. O. and Winsett, R. (1990) Effects of theophylline on erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplantation. N. Engl. J. Med. 323: 86-90.
4. Barraco, R. A. (1991) Behavioral actions ot adenosine and related substances. In: Adenosine and Adenine Nucleotides as Regulators of Cellular Functions, pp. 339-366, Phillis, J. W. (ed.) CRC Press, Boca Raton.
5. Barraco, R. A., Phillis, J. W. and Altman, H. J. (1985) Depressant effect of forskolin on spontaneous locomotor activity in mice. Gen. Pharmacol. 16: 521-524.
6. Barraco, R. A., Janusz, C. A., Schoener, E. P. and Simpson, L. L. (1990) Cardiorespiratory function is altered by picomole injections of 5′-N-ethylcarboxamidoadenosine into the nucleus tractus solitarius of rats. Brain Res. 507: 234-246.
7. 2a receptors in the nucleus accumbens. Prog. Neuropsychopharmacol. Biol. Psychiatry 18: 545-553.
8. 2-adenosine receptor binding subunit. Mol. Pharmacol. 38: 177-183.
9. Belardinelli, L., Linden, J. and Berne, R. M. (1989) The cardiac effects of adenosine. Prog. Cardiovasc. Dis. 32: 73-97.
10. Berne, R. M. (1986) Adenosine: an important physiological regulator. News Physiol. Sci. 1: 163-167.
11. Bruns, R. F. (1980) Adenosine receptor activation in human fibroblasts: nucleoside agonists and antagonists. Can. J. Physiol. Pharmacol. 58: 673-691.
12. 3H]NECA in rat striatal membranes. Mol. Pharmacol. 29: 331-346.
13. 2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells. Mol. Pharmacol. 44: 950-958.
14. Collis, M. G. and Hourani, S. M. O. (1993) Adenosine receptor subtypes. Trends Pharmacol. Sci. 14: 360-366.
15. Cronstein, B. N. (1994) Adenosine, an endogenous anti-inflammatory agent. J. Appl. Physiol. 76: 5-13.
16. 2- generation, respectively. J. Clin. Invest. 85: 1150-1157.
17. 2a receptors in the rat hippocampus. Brain Res. 649: 208-216.
18. Daly, J. W., Butts-Lamb, P. and Padgett, W. (1983) Subclasses of adenosine receptors in the central nervous system. Interaction with caffeine and related methylxanthines. Cell. Mol. Neurobiol. 36: 69-80.
19. Daval, J. L., Nehlig, A. and Nicolas, F. (1991) Physiological and pharmacological properties of adenosine: therapeutic implications. Life Sci. 49: 1435-1453.
20. Deckert, J. and Gleiter, C. H. (1994) Adenosine - an endogenous neuroprotective metabolite and neuromodulator. J. Neural Transm. Suppl. 43: 23-31.
21. Dionisotti, S., Zocchi, C., Varani, K., Borea, P. A. and Ongini, E. (1992) Effects of adenosine derivatives on human and rabbit platelet aggregation. Correlation of adenosine receptor affinities and antiaggregatory activity. Naunyn Schmiedebergs Arch. Pharmacol. 346: 673-676.
22. Dirnagl, U., Niwa, K., Lindauer, U. and Villringer, A. (1994) Coupling of cerebral blood flow to neuronal activation: role of adenosine and nitric oxide. Am. J. Physiol. 267: H296-H301.
23. 2 receptors and their coupling to G-proteins. Dev. Brain Res., in press.
24. 1 receptors inhibit adenylate cyclase activity and neurotransmitter release and hyperpolarize pyramidal neurons in rat hippocampus. J. Pharmacol. Exp. Ther. 249: 31-37.
25. Durcan, M. J. and Morgan, P. F. (1989) NECA-induced hypomotility in mice: evidence for a predominantly central site of action. Pharmacol. Biochem. Behav. 32: 487-490.
26. 2 receptors induces catalepsy. Neurosci. Lett. 130: 162-164.
27. 2 receptors in rat striatal membranes. Proc. Natl. Acad. Sci. USA 88: 7237-7241.
28. Ferré, S., Fuxe, K., von Euler, G., Johansson, B. and Fredholm, B. B. (1992) Adenosine-dopamine interactions in the brain. Neuroscience 51: 501-512.
29. 2 dopamine receptors in rat striatum. Mol. Brain Res. 14: 186-195.
30. Forrester, T., Harper, A. M. and MacKenzie, E. T. (1979) Effect of adenosine triphosphate and some derivatives on cerebral blood flow and metabolism. J. Physiol. 296: 343-355.
31. Fredholm, B. B. (1995) Adenosinc receptors in the central nervous system. News Physiol. Sci. 10: 122-128.
32. Fredholm, B. B., Johansson, B., van der Ploeg, I., Hu, P. S. and Jin, S. (1993) Neuromodulatory roles of purines. Drug Dev. Res. 28: 349-353.
33. Fredholm, B. B., Abbracchio, M. P., Burnstock, G., Daly, J. W., Harden, T. K., Jacobson, K. A., Leff, P. and Williams, M. (1994) Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46: 143-156.
34. 2-adenosine receptors in isolated tubules of the rabbit renal cortex. Eur. J. Pharmacol. 138: 137-140.
35. Fuller, R. W., Maxwell, D. L., Conradson, T. B. G., Dixon, C. M. S. and Barnes, P. J. (1987) Circulatory and respiratory effects of infused adenosine in conscious man. Br. J. Clin. Pharmacol. 24: 309-317.
36. 2a receptor. Mol. Brain Res. 15: 62-66.
37. 2 receptor antagonist, reduces cerebral ischemic injury in the mongolian gerbil. Life Sci. 55: 61-65.
38. Gerfen, C. R. (1992) The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci. 15: 133-139.
39. 2 adenosine receptor antagonists, CGS 21197 and CGS 22706, in mice. Neuroreport 2: 139-140.
40. 6-cyclohexyladenosine on local cerebral blood flow and glucose utilization in the conscious rat. Acta Physiol. Scand. 127: 86-89.
41. Gubits, R. M., Wollack, J. B., Yu, H. and Liu, W. K. (1990) Activation of adenosine receptors induces c-fos, but not c-jun, expression in neuron-glia hybrids and fibroblasts. Mol. Brain Res. 8: 275-281.
42. Gurden, M. F., Coates, J., Ellis, F., Evens, B., Foster, M., Hornby, E., Kennedy, I., Martin, D. P., Strong, P., Vardey, C. J. and Wheeldon, A. (1993) Functional characterisation ot three adenosine receptor types. Br. J. Pharmacol. 109: 693-698.
43. Haedrick, J. P. and Berne, R. M. (1990) Endothelium-dependent and independent relaxations to adenosine in guinea pig aorta. Am. J. Physiol. 259: H62-H67.
44. 2 receptors in the striatum of the rat following chronic treatment with diazepam. Neuropharmacology 27: 1131-1140.
45. Heistad, D. D., Marcus, M. L., Gourley, J. K. and Busija, D. W. (1981) Effect of adenosine and dipyridamole on cerebral blood flow. Am. J. Physiol. 240: H775-H780.
46. 2a adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase. Mol. Pharmacol. 41: 352-359.
47. Howell, L. L. (1993) Effects of adenosine agonists on ventilation during hypercapnia, hypoxia and hyperoxia in rhesus monkeys. J. Pharmacol. Exp. Ther. 265: 971-978.
48. 2 selective adenosine receptor agonist with preferential hypotensive activity. J. Pharmacol. Exp. Ther. 251: 47-55.
49. 2 receptor ligands. J. Med. Chem. 33: 1919-1924.
50. 3H]-adenosine binding in relation to adenylate cyclase activity. Naunyn Schmiedebergs Arch. Pharmacol. 325: 226-233.
51. Irestedt, L., Dahlin, I., Hertzberg, T., Sollevi, A. and Lagercrantz, H. (1989) Adenosine concentration in umbilical cord blood of newborn infants after vaginal delivery and cesarean section. Pediatr. Res. 26: 106-108.
52. 2-adenosine antagonist in vitro and in vivo. FEBS Lett. 323: 141-144.
53. Jain, N., Kemp, N., Adeyemo, O., Buchanan, P. and Stone, T. W. (1995) Anxiolytic activity of adenosine receptor activation in mice. Br. J. Pharmacol. 116: 2127-2133.
54. 2-selective adenosine analog, CGS 21680, depresses locomotor activity but does not block amygdala kindled seizures in rats. Neurosci. Lett. 141: 247-250.
55. 3H]CGS 21680. Eur. J. Pharmacol. 168: 243-246.
56. 2 receptors in rat brain. J. Pharmacol. Exp. Ther. 251: 888-893.
57. 2-adenosine receptors using radioligand binding and photoaffinity labeling. J. Recept. Res. 12: 149-169.
58. 3H]CGS 21680 to rat brain using autoradiography. Neuropharmacology 34: 393-403.
59. 2 adenosine receptor binding and on mRNA levels in rat brain. Naunyn Schmiedebergs Arch. Pharmacol. 347: 407-414.
60. Johansson, B., Lindström, K. and Fredholm, B. B. (1994) Differences in the regional and cellular localization of c-fos messenger RNA induced hy amphetamine, cocaine and caffeine in the rat. Neuroscience 59: 837-849.
61. 2+ does not uncouple adenosine "Rs" receptors from the liver adenylate cyclase. Biochem. Biophys. Res. Commun. 105: 347-353.
62. 3H]acetylcholine release. J. Neurochem. 62: 960-966.
63. 2a receptor is not mediated by increases in cyclic AMP. J. Neurochem. 64: 2801-2809.
64. Lagercrantz, H. (1994) The role of adenosine in neonatal adaptation. Neonatal Monitor 10: 2-5.
65. Laudignon, N., Beharry, K., Farri, E. and Aranda, J. V. (1991) The role of adenosine in the vascular adaptation of neonatal cerebral blood flow during hypotension. J. Cereb. Blood Flow Metab. 11: 424-431.
66. Lewis, C. D., Hourani, S. M. O., Long, C. J. and Collis, M. G. (1994) Characterization of adenosine receptors in the rat isolated aorta. Gen. Pharmacol. 25: 1381-1387.
67. Liang, B. T. (1992) Adenosine receptors and cardiovascular function. Trends Cardiovasc. Med. 2: 100-108.
68. Libert, F., Parmentier, M., Lefort, A., Dinsart, C., Van Sande, J., Maenhaut, C., Simons, M. J., Dumont, J. E. and Vassart, G. (1989) Selective amplification and cloning of four new members of the G protein-coupled receptor family. Science 244: 569-572.
69. 3 adenosine receptor with widespread tissue distribution. Mol. Pharmacol. 44: 524-532.
70. 3H]NECA binding sites by gel filtration. Naunyn Schmiedebergs Arch. Pharmacol. 337: 64-68.
71. 2a adenosine receptors in rat brain. J. Neurochem. 65: 2072-2079.
72. 2 receptor with physiological constitutive activity. Biochem. Biophys. Res. Commun. 173: 1169-1178.
73. 2 receptors: selective localization in the human basal ganglia and alterations with disease. Neuroscience 42: 697-706.
74. 2+ influx and activates a protein phosphatase in bovine adrenal chromaffin cells. J. Neurochem. 64: 77-84.
75. 2a receptor modulation of electrically evoked endogenous GABA release from slices of rat globus pallidus. J. Neurochem. 60: 2334-2337.
76. 2 adenosine receptor in rat striatal membranes. Drug Dev. Res. 28: 369-373.
77. McBean, D. E., Grome, J. J. and Harper, A. M. (1989) A cerebral vasoconstrictive effect of some adenosine analogues. A study of adenosine analogues on local cerebral blood flow and glucose utilisation in the rat. J. Cereb. Blood Flow Metab. 9: 548-555.
78. 2a adenosine receptor from guinea pig brain. Neurochem. Res. 19: 613-621.
79. Meno, J. R., Ngai, A. C., Ibayashi, S. and Winn, R. (1991) Adenosine release and changes in pial arteriolar diameter during transient cerebral ischemia and reperfusion. J. Cereb. Blood Flow Metab. 11: 986-993.
80. 2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine-lesioned rats. Neuroscience 67: 49-55.
81. Nakajima, T., Daval, J. L., Morgan, P. F., Post, R. M. and Marangos, P. J. (1989) Adenosinergic modulation of caffeine-induced c-fos mRNA expression in mouse brain. Brain Res. 501: 307-314.
82. 2 receptor agonists and antagonists on local rates of energy metabolism in the rat brain. Eur. J. Pharmacol. 258: 57-66.
83. Nicolas, F., Oillet, J., Koziel, V. and Daval, J. L. (1994) Characterization of adenosine receptors in a model of cultured neurons from rat forebrain. Neurochem. Res. 19: 507-515.
84. 3H]CGS 21680 as a ligand. Naunyn Schmiedenbergs Arch. Pharmacol. 342: 85-89.
85. Phillis, J. W. (1989) Adenosine in the control of the cerebral circulation. Cerebrovasc. Brain Metab. Rev. 1: 26-54.
86. 2 receptor agonist, CGS 21680, is a potent depressant of cerebral cortical neuronal activity. Brain Res. 509: 328-330.
87. Phillis, J. W., Barraco, R. A., DeLong, R. E. and Washington, D. O. (1986) Behavioral characteristics of centrally administered adenosine analogs. Pharmacol. Biochem. Behav. 24: 263-270.
88. 2b receptor from human brain. Biochem. Biophys. Res. Commun. 187: 86-93.
89. 2 dopamine receptor mRNA in striatal output pathways following a selective lesion of striatonigral neurons. Brain Res. 631: 161-166.
90. 2a selective receptor antagonist. Br. J. Pharmacol. 115: 1096-1102.
91. 2b receptor. Mol. Pharmacol. 47: 1126-1132.
92. 1MF-2 cells. Mol. Pharmacol. 40: 639-647.
93. 2 antagonists. Neuroreport 2: 661-664.
94. Rubio, R., Berne, R. M., Bookman, E. L. and Curnish, R. R. (1975) Relationship between adenosine concentration and oxygen supply in rat brain. Am. J. Physiol. 228: 1896-1902.
95. Rudolphi, K. A., Schubert, P., Parkinson, F. E. and Fredholm, B. B. (1992) Adenosine and brain ischemia. Cerebrovasc. Brain Metab. Rev. 4: 346-369.
96. 2 adenosine receptors. Int. J. Purine Pyrimidine Res. 3: 82.
97. 2 receptor in the striatum: early localization in the patch compartment. J. Comp. Neurol. 317: 117-128.
98. 2 receptors regulate the gene expression of striatopallidal and striatonigral neurons. J. Neurosci. 13: 1080-1087.
99. 2 receptor (RDC8) is expressed by enkephalin by not by substance P neurons: an in situ hybridization histochemistry study. J. Neurochem. 57: 1062-1067.
100. 2 receptor mRNA in the human brain. Neurosci. Lett. 130: 177-181.
101. 2 adenosine receptors in the rat hippocampus. Neurosci. Lett. 138: 41-44.
102. Shi, D., Nikodijevic, O., Jacobson, K. A. and Daly, J. W. (1993) Chronic caffeine alters the density of adenosine, adrenergic, cholinergic, GABA and serotonin receptors and calcium channels in mouse brain. Cell. Mol. Neurobiol. 13: 247-261.
103. 2 antagonists. J. Med. Chem. 35: 2342-2345.
104. Simpson, R. E., O'Regan, M. H., Perins, L. M. and Phillis, J. W. (1992) Excitatory transmitter amino acid release from the ischemic rat cerebral cortex: effects of adenosine receptor agonists and antagonists. J. Neurochem. 58: 1683-1690.
105. 2-adenosine receptor subtype. Mol. Endocrinol. 6: 384-393.
106. Van Calker, D., Muller, M. and Hamprecht, B. (1979) Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J. Neurochem. 33: 999-1005.
107. Van Wylen, D. G. L., Par, T. S., Rubio, R. and Berne, R. M. (1989) The effect of local infusion of adenosine and analogues on local cerebral blood flow. J. Cereb. Blood Flow Metab. 9: 556-562.
108. 2-Purinoreceptor-mediated relaxation in the guinea-pig coronary vasculature: a role for nitric oxide. Br. J. Pharmacol. 109: 424-429.
109. Wachtel, H. (1983) Potential antidepressant activity of rolipram and other selective 3′,5′-monophosphate phosphodiesterase inhibitors. Neuropharmacology 22: 267-272.
110. Wakade, T. D., Palmer, K. C., McCauley, R., Przywara, D. A. and Wakade, A. R. (1995) Adenosine-induced apoptosis in chick embryonic sympathetic neurons: a new physiological role for adenosine. J. Physiol. (Lond.) 488: 123-138.
111. 2 receptor binding in superior colliculus of rat. Neurosci. Lett. 117: 160-164.
112. 3H]CGS 21680 to human and rat brain: evidence for multiple affinity sites. J. Neurochem. 55: 1763-1771.
113. 2a adenosine receptor gene expression in developing rat brain. Mol. Brain Res. 20: 313-327.
114. Williams, M. (1993) Purinergic drugs: opportunities in the 1990s. Drug Dev. Res. 28: 438-444.